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Abstract
Objective—With important technological advances in healthcare delivery and the internet,
clinicians and scientists now have access to overwhelming number of available databases
capturing patients with critical illness. Yet investigators seeking to answer important clinical or
research questions with existing data have few resources that adequately describe the available
sources and the strengths and limitations of each. This article reviews an approach to selecting a
database to address health services and outcomes research questions in critical care, examines
several databases that are commonly used for this purpose, and briefly describes some strengths
and limitations of each.
Data Sources—Narrative review of the medical literature.
Summary—The available databases that collect information on critically ill patients are
numerous and vary in the types of questions they can optimally answer. Selection of a data source
must not only consider accessibility, but also the quality of the data contained within the database,
and the extent to which it captures the necessary variables for the research question. Questions
seeking causal associations (e.g. effect of treatment on mortality) usually either require secondary
data that contain detailed information about demographics, laboratories, and physiology to best
address non-random selection or sophisticated study design. Purely descriptive questions (e.g.
incidence of respiratory failure) can often be addressed using secondary data with less detail such
as administrative claims. Though each database has its own inherent limitations, all secondary
analyses will be subject to the same challenges of appropriate study design and good observational
research.
Conclusion—The literature demonstrates that secondary analyses can have significant impact on
critical care practice. While selection of the optimal database for a particular question is a
necessary part of high-quality analyses, it is not sufficient to guarantee an unbiased study.
Thoughtful and well-constructed study design and analysis approaches remain equally important
pillars of robust science. Only through responsible use of existing data will investigators ensure
that their study has the greatest impact on critical care practice and outcomes.
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Introduction
Clinicians and scientists have witnessed an unprecedented expansion in the publication of
critical care studies employing observational designs. This expansion is perhaps most
evident in studies using secondary data. Secondary data can be defined as data gathered for
one reason (e.g. clinical trial) now being reemployed to answer a novel question (e.g. costs
of care), whereas primary data are data collected specifically for the purposes of answering a
novel question (1). Several factors are responsible for this expansion, including wide
recognition of the importance of safety and quality improvement research (2-5), the ability
to perform complex analytic tasks on personal computers, and growth in the cadre of
investigators capable of performing secondary analyses through methods training(6, 7).
When done well, this work has contributed novel observations and changed practice in
fundamental ways, improving outcomes for patients. At the bedside, the re-evaluation of
pulmonary artery catheters—once a ubiquitous feature of nearly every medical ICU patient
—began with a clever re-analysis of a clinical trial done to investigate other questions(8).
Modern ICU organization—with its focus on high-volume centers of excellence—was
shaped by scientific observations about the volume/outcome relationship(9, 10) and by the
rigorous evaluation of the surgical and trauma center experience(11-13).
Secondary data analyses also provide essential raw material for key operations in healthcare.
National priority setting about causes of death and clinical decision-making about prior
probabilities of disease both depend on secondary data. For example, virtually every basic-
science grant application on severe sepsis contextualizes the proposed work with national-
scale epidemiology derived from administrative records(14, 15). Current policy concerns
about healthcare overuse in the ICU such as excessive end-of-life spending and unexplained
geographical variation in ICU use depend on secondary data analyses(16-20). Much of our
understanding of racial/ethnic and insurance-based disparities(21-28), as well as the value of
critical care(29-32), derive from secondary data analyses. This work has helped move the
conversation about the causes for inequities in critical care away from personal opinion
toward scientific evaluation and efforts to solve such problems.
This new scientific and clinical importance of secondary data analysis has regrettably been
accompanied by numerous examples of poorly designed studies utilizing datasets ill
equipped to answer the research questions posed of them(33). A major contributor to the
evolution of secondary analyses is the dramatic growth in existing critical care databases and
the ease with which one can access them. Despite the attractiveness of such data for many
purposes, there have been few references to turn to that discuss available data sources
relevant to critical care to facilitate informed choices by prospective investigators(1, 7,
34-36).
In this review, we examine several existing critical care data sources commonly used for
secondary data analysis in critical care, and present a practical approach to the selection of a
database based upon the strengths of the source. We limit our discussion to databases used
for the conduct of clinical epidemiology, health service, policy and outcomes research,
rather than discuss data derived from genetic analyses, “-omics”, or other bench science.
Although there are important critical care data resources outside of the United States(37-39),
we focus on resources within. Our target audience includes both investigators seeking to
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answer research questions in critical care, but also readers of the medical literature interested
in ways to better appraise the data sources selected in published studies. Finally, we focus on
the secondary data available for answering well-formed questions, but do not seek to review
fundamentals of good scientific study design.
Why use secondary data?
Investigators who employ secondary data to answer clinical questions can capitalize on
several of its advantages compared to primary data. First, secondary analysis of data
promotes efficient use of research investments particularly when performed on biologic data
or data otherwise overly expensive to collect. Second, there are some questions (e.g. where
randomization is unethical or measuring “real-world” practice) that often can only or are
most efficiently answered by secondary data analysis. Third, some secondary data, such as
large registries and administrative data, may provide greater generalizabilty due to a much
greater scope than studies collecting primary data—potentially generalizing to regions,
states, or even the nation. Fourth, it may be feasible to carry out a secondary data analysis
for questions where primary data collection is too onerous, such as those that consider 5- or
10-year follow-ups. Similarly, scientists with appropriate statistical training but with limited
grant funding may find secondary data analysis more feasible as a first approach to a
problem. Fifth, because some secondary analyses employ administrative data that are very
large, they may provide a much more precise estimate of effect than smaller primary studies,
particularly for rare diagnoses. Sixth, when secondary data cannot be used to answer the
appropriate scientifically rigorous and clinically relevant question, they may play an
important supplementary role to assess the plausibility and likelihood of success of a large-
scale primary data collection effort; secondary data analysis may be a particularly cost-
effective way to obtain such preliminary data. For example, the secondary analysis of the
SUPPORT study, which suggested pulmonary artery catheters were harmful, formed the
basis for several randomized trials. Finally, secondary analyses of administrative data may
be more relevant to policymakers and therefore support the translation of scientific
discoveries into improved care. For example, Medicare stakeholders base policy decision on
research that is conducted using data from Medicare patients.
Selecting a data source
The issues that a researcher confronts when evaluating a database for secondary analysis are
the same that readers of the literature must consider when assessing the quality of a data
source used in a published study. However, because investigators ultimately need to obtain
the data in addition to critiquing it, we approach the database evaluation and acquisition
process from the perspective of a researcher.
Data quality
When confronted with the overwhelming number of existing data sources, investigators
must first consider the ability of a given data source to sufficiently address the research
question of interest. This involves characterizing the quality and overall susceptibility to bias
of the data source. While this process largely remains a subjective task(40, 41), in 2003 a
group of investigators from the United Kingdom developed a framework to assess the
quality of secondary databases(42). The framework included two aspects characterizing
database quality: coverage and accuracy(Table 1). While useful in principle, this framework
is not sufficient to identify an optimal database. By placing equal value on each aspect of
database quality, it ignores how the potential for inadequacies in a single domain may be
fatal to a study. Most obviously, a database may be perfect in all domains yet lack the
outcome variable of interest.
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Taxonomy of the question
A more practical approach to the selection of a data source considers the needs imposed by
the research question. Through articulating a well-defined research question, an investigator
will know which variables are needed to define the population, the treatment or exposure,
the outcomes, and those needed for adjustment (i.e. confounding variables), such as
demographics and severity of illness(43). One can then consider whether clinically detailed
versus clinically sparse data are needed to address the question. Many quantitative research
questions can be lumped into five overlapping groups that describe the goals of the study
(Table 2). The goals of the study often dictate the need for clinically rich versus sparse
information. When investigators seek to determine the causal relationship between a risk
factor and outcome or compare outcomes across specific treatments, greater clinical
information is usually necessary to address confounding – that is, account for any variable
that may distort the relationship between the observed exposure and outcome(44). Often, the
most important confounding variable is severity of illness(7, 44).
In contrast, more descriptive questions that characterize the epidemiology of disease, clinical
practice, health service use, and health care spending, are not usually limited by
confounding because comparisons between different groups are less often performed. For
example, Wiener and colleagues used national hospital discharge claims to examine
temporal changes in use of pulmonary artery catheters(45). The absence of clinically
detailed information in this study did not impact the importance of this result given its
descriptive nature.
While the taxonomy of questions in Table 2 may be helpful to articulating the needs for a
given question, we do not intend it to be prescriptive or without exception. For example,
there are many excellent examples of investigators employing clinically sparse data to
examine causal relationships(10, 46) and clinically rich information to examine disease
incidence(47). Clinically rich information often has the benefit of being able to address
many types of questions, but the same is not necessarily true for clinically sparse
information. When sparse data are used to examine causal relationships more sophisticated
methods to address patient selection and confounding are needed(44, 48-51).
Mapping the question to the data
Only after an investigator has decided on the variables needed to address the question and
has considered the importance of clinically rich versus sparse data, should he or she
investigate the available databases in which to study the question. A prudent approach
toward finding a source requires searching of the web, the literature, and discussions with
investigators who have used secondary data. Once potential sources are identified, an
important next step is to determine if access to the data is feasible. Some secondary data
sources can be downloaded from the web free of charge, but others have fees that can range
from $20 to over $100,000. Independent of access fees, some sources require navigating
administrative hurdles, including vetting the research proposal by an oversight committee, or
require collaboration with a scientist that has access to the data. While in no way
comprehensive, Table 3 describes the several critical care databases organized by the degree
of clinical detail available within each and qualitatively describes the accessibility of each
data source.
Available data sources
Publicly available clinical trials and cohort studies
Nationally funded randomized controlled trials (RCT) and large-scale prospective cohort
studies usually collect data with considerable clinical detail, including clinical physiology,
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severity of illness, and patient outcomes. One of the most important existing repositories for
critical care RCTs and cohort studies is the National Heart, Lung, and Blood Institute's
Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC)(52).
BioLINCC provides data from over 80 clinical and epidemiological studies. These include
many prominent critical care studies from the last few decades, particularly the ARDSNet
RCTs conducted from 1996 through 2006(53-58)—use of which has resulted in dozens of
secondary analyses.
Electronic medical record
The electronic medical record (EMR) has great promise to become the future source of
many secondary data analyses(59, 60). Unfortunately, several important barriers hamper the
current realization of the research potential of the EMR, including difficulty in extracting
information from free text, and compatibility of systems across hospitals(60). Nevertheless,
there have been successes.
The Department of Veterans Affairs created the Inpatient Evaluation Center (IPEC), an
infrastructure for improving the quality of care in VA medical centers that includes data on
all inpatients in over 100 hospitals extracted from the VA's EMR. This data source includes
an excellent risk-adjustment measure and has been used to study the organization and
quality of care within the VA(61, 62), develop risk-adjustment models(63, 64), and
determine the impact of infection control measures on outcomes(65, 66). Kaiser Permanente
of Northern California has similarly rich data on its large network of community
hospitals(67).
An additional EMR-based resource is the Multiparameter Intelligent Monitoring in Intensive
Care II (MIMIC-II) database(68). This publicly available, deidentified repository includes
minute-to-minute data for over 30,000 patients admitted to an ICU in Beth Israel Deaconess
Medical Center. Published studies using the MIMIC-II database have examined several
aspects of ICU care such as, developing and validating high-fidelity risk-adjustment
models(69, 70), and characterizing providers' response to hypotension(71, 72). Users can
gain access to MIMIC-II via the internet.
Quality Improvement and Benchmarking
Several existing data sources that were created for benchmarking or quality improvement
purposes provide clinically rich data on ICU patients. Perhaps the most famous of these is
the APACHE database(73). By maintaining the gold standard for risk-adjustment, the
APACHE database provides rich clinical information for patients in hospitals that
voluntarily contribute data. Investigators have used this source to answer questions about the
impact of organizational features on patient outcomes(74, 75), variation in ICU admission
practice(76), volume-outcome relationships(9), among others. Cerner, the owner of
APACHE, also previously maintained the now unavailable Project IMPACT(77, 78).
A relatively new data source of critically ill patients is the eICU Research Institute(79).
Although designed to allow off-site intensivist involvement in remote ICUs, telemedicine
systems also standardize disparate data from participating ICUs(80). Phillips eICU (formerly
VISICU), currently the largest vendor of ICU telemedicine, created the eICU Research
Institute in collaboration with health-care providers and academia(80, 81). The University of
Maryland School of Pharmacy Pharmaceutical Research Computing Center (PRC) is the
first academic partner with access to this database.
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Registries
Although the line distinguishing a registry from quality improvement or benchmarking
database is somewhat arbitrary, registries usually focus on a single disease or syndrome and
are often use by their participants to benchmark their own data to that of others. For
example, the National Trauma Data Bank maintains the largest nationally representative
sample of patients experiencing trauma. Data fields include demographics, vital signs from
the ED and EMS, abbreviated injury scale, procedure and diagnosis codes, ICU and
ventilator days, among other characteristics. Prominent past studies employing this data
source have looked at the impact of helicopter transport(82), the pulmonary artery
catheter(83), and prehospital fluids(84) on outcomes of trauma.
The American Heart Association Get with the Guidelines (GWTG) maintains several
registries capturing patients that often require critical care services. The GWTG-
Resuscitation collects information on consecutive patients with in-hospital cardiac arrests,
defined by the absence of a central palpable pulse, apnea, and unresponsiveness(85).
Extensive data surrounding the arrest and the post hospital course is collected including
outcomes of return to spontaneous circulation, neurologic status, and survival to discharge.
Recent studies employing this dataset include analyses examining cardiac arrest among
patients with pneumonia(86), variation in hospital cardiac arrest rates(87, 88) and in the time
to defibrillation(89), and racial differences in outcomes after arrest(90).
Administrative data/utilization claims
Administrative data are data collected on patients during encounters with the healthcare
system and are most often collected for billing insurers. For hospitalized patients, this
usually includes data from the Uniform Billing 04 sheet (UB-04) which collects facility
charges during an inpatient stay(91). Although elements vary by payer, this form typically
collects demographics including payer, admission source, ICD-9-CM diagnosis and
procedure codes, DRG codes, some CPT and/or HCPCS codes, length of stay, disposition,
hospital identifier, and detailed charges for aspects of the hospital stay (e.g. ICU room and
board, pharmacy). Although encounter-specific, claims can often be linked allowing one to
trace an individuals course through inpatient, post-discharge, and outpatient facilities.
The two main sources of administrative data include insurers and government agencies
interested in tracking healthcare use. For example, Medicare provides research claims for all
aspects of care among its close to 50 million beneficiaries across the entire United States, a
segment of the population that accounts for a majority of critical care use(92) and of
intrinsic public policy interest. Long-term mortality and longitudinal utilization can be
tracked in Medicare files. Access to Medicare data is relatively expensive if one's research
question requires individual-level linkage across hospitals or outpatient claims; in contrast,
one year's standard inpatient file, so-called “MedPAR” files, can cost less than $1,000.
MedPAR includes information about the inpatient stay typically present on the UB-04 form,
including diagnosis, procedure, and DRG codes, ICU or CCU stay, hospital charges, and
hospital discharge disposition. Data about skilled nursing stays are also included. However,
information about outpatient visits, physician charges, durable medical equipment, and
hospice care are in separate files. Investigators have used Medicare data to examine long
term survival of respiratory failure(93), epidemiology of sepsis(94), cognitive outcomes
among critically ill patients(95), and epidemiology of long-term acute care use(96).
In contrast to Medicare, some data sources include data from all payers. These include
various state health departments or agencies such as the CDC that maintain national surveys
of inpatient care(97). The Healthcare Cost and Utilization Project (HCUP), the largest
collection of all-payer inpatient care data in the US maintains one of the most accessible
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sources of administrative data(98). Investigators can access over 95% of ER visits and
hospital discharges from individual states using HCUP's State Emergency Database or the
State Inpatient Database, or use HCUP's Nationwide Inpatient Database to examine
questions in a nationally representative sample of hospitals and patients. Data are also
available for children. Readmissions are tracked in several states; however, follow-up to out-
of-hospital patient-centered outcomes is often impossible. HCUP has been used to examine
variation in ICU use(19, 99), stroke risk among patients with atrial fibrillation and
sepsis(100), longitudinal trends in PA catheter use(45), and impact of marital status on
sepsis outcomes(101). Finally, private groups or insurers also maintain research files that
can be purchased at significant costs. These include MarketScan, a data source representing
diverse claims from over 100 private payers(102), and Premier Perspective, the nations
largest inpatient drug utilization database. Premier Perspective is unique in its collection of
time stamped data about medications delivered during an inpatient stay. Investigators have
capitalized on this unique attribute to examine the impact of activated protein C on mortality
in sepsis(103), and the quality of care among patients admitted with COPD
exacerbations(104, 105).
Linking data sources
Often a single dataset may provide only part of the information that is necessary to conduct
a successful analysis. In such situations investigators can either supplement the data source
by collecting additional data or link two or more existing data sources. For example,
Treggiari and colleagues successfully linked an existing ARDS database to a prospective
survey of ICU directors to determine the relationship between physician staffing and
outcomes of ARDS(106).
The often-easier option involves the linking of two independent but preexisting data sources
that together have the necessary information for the question. Occasionally, this linkage has
already been done prior to obtaining the data. For example, the Health and Retirement Study
collects data on the sources beneficiaries use to pay for services, health status, and other
economic and family variables from nationally representative samples of older Americans.
An existing link to Medicare files allows one to identify survey respondents who were
hospitalized with critical illness. Iwashyna et al.(95) used this data, and Barnato et al.(107)
capitalized on the similar Medicare Current Beneficiary Study to examine disability of long-
term survivors of critical illness. Such linkage offers an unusual opportunity to examine
outcomes for rarer diseases with prospectively collected pre-morbid data(108). An
additional pre-linked data source is the Surveillance Epidemiology and End Results linked
to Medicare files (SEER-Medicare)(109). SEER collects information on cancer incidence,
prevalence and survival from specific geographic areas containing 28 percent of the US
population. Through an existing link to Medicare inpatient files, one can examine the
intersection between cancer and critical care, such as the relationship between critical illness
and long-term survival among lung cancer patients(110). When links are not already in
place, investigators can often establish them provided identifying information is present
within the data. For example, Seymour and colleagues linked paramedic run sheets with WA
state hospital discharge claims to study prehospital risk factors for ICU admission and
hospital mortality(111).
Limitations of available databases
While many databases described above are limited by their lack of clinical detail, all have
additional unique limitations. Most RCTs in critical care enroll only a small fraction of
eligible patients, which may threaten generalizability of secondary analyses using RCTs as a
data source. Many registries or databases collected for quality improvement and
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benchmarking efforts include only volunteer hospitals. These non-random hospitals may be
highly motivated to improve care for their patients, are often geographically clustered, and
are more likely to be teaching hospitals, factors that threaten generalizability of studies
employing these data sources(7). Administrative data are limited by the often-unknown
validity of ICD-9-CM or other billing codes for identifying critical illness, variable number
of ICD-9-CM codes collected across hospitals(112), temporal instability in coding
practice(113), biases due to provider efforts to maximize payment(114), among others.
Investigators using these databases should consider how these limitations might bias their
results and include strategies in their analyses that address these weaknesses. These
limitations suggest that the optimal approach to an avenue of research uses secondary data
for the questions that they are uniquely suited to address, but turns to primary data for other
aspects of the key clinical questions.
Finally, and perhaps most crucially, databases only provide the raw materials to address a
research question but do nothing to ensure a study is appropriately designed and conducted.
Observational research—indeed, all research—regardless of the study design or data source,
is subject to a variety of biases in addition to the issues of confounding.
Speculations about the future
A major barrier to optimal care for all critically ill patients is absence of a centralized
repository of data on critically ill patients in the US—despite the fact that such a barrier is
surmountable. Policymakers and scientists have used available registries of patients with
cardiac disease, including those described above, not only to increase guideline concordant
care, but also to gain important insights about the care for patients with congestive heart
failure, myocardial infarction, and cardiac arrest(87, 115-117). Leaders within the American
College of Surgeons have driven continuing improvements in trauma and surgical outcomes
through trauma registries and the National Surgical Quality Improvement Program
registry(118, 119). Registries have even been successfully implemented in combat zones to
improve care of wounded soldiers(120). Armed with high-quality clinical practice
guidelines, policymakers in cardiology and surgery have developed clinical registries by
capitalizing on strong leadership and financing from professional societies. Despite the
existence of guidelines for management of some critically ill populations, such as sepsis,
leaders in critical care have been less successful in their efforts to create comparably
accessible and comprehensive registries(121). As leaders within professional critical care
societies strive to guide practice through publication and implementation of guidelines, they
should continue to pursue parallel efforts to track the populations targeted by their
guidelines to ensure that optimal care is being delivered in the real world. As we have
witnessed in cardiology and surgery, secondary analyses of such critical care registries could
realize further gains in the care for our patients.
Conclusions
Through secondary data analyses, investigators have provided a large contribution to the
understanding of disease and heath care delivery in critical care. This past work is an
important reminder that rigorous observational science is not only possible it is essential to
further improve the care delivered to critically ill patients. Scientists using existing data for
research also promote a more efficient research agenda because they maximizes the
knowledge that can be gained from the past, often expensive efforts to gather data(122).
Investigators using secondary data must carefully consider the advantages and disadvantages
of each potential data source prior to selecting one or more for their analyses. Through
applying a rigorous approach to database selection and data quality assessment, investigators
will be well on their way ensure that their study will have the greatest impact.
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Table 1
Aspects of databases that reflect the quality of data contained within
Quality Domain Explanation
Coverage
Representativeness How well does the data source represent the population that it intends to?
Completeness of recruitment This feature measures the extent to which all eligible individuals have been included in the data collection
scheme
Variables included What is the extent of the data collected on each individual? Are demographic, exposure, outcome, and
confounding variables present?
Completeness of variables What is the extent of the missing data?
Accuracy
Collection of raw data Is the raw data collected or are aggregate averages collected?
Explicit definitions Are the variables explicitly defined?
Explicit rules Are there explicit rules for deciding how variables are recorded? For example, the timing of physiologic
variables.
Reliability of coding Was the reliability of coded conditions and interventions tested?
Independence of observations Was the data recorder blinded to patient outcome at the time the data were collected?
Data validation Were data validated using outside sources? Were there consistency checks?
Based upon Black, et al.(42)
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Table 2
Assessing the research goal and types of questions answered using existing data
Assessing the
Research Goal Types of Questions Answered
Need for
Clinical
Detail Notes
Determine the causal
relationship between
risk factor and outcome
• What is the relationship between to recruitment
maneuvers and complications in patients with
ARDS?(123)
• What is the association between refractory
hypotension and long-term cognitive function
among survivors of sepsis?
High In select situations, one can use
advanced methods for causal
inference to attempt to overcome
confounding by severity of illness
such as propensity scores,
instrumental variables, or quasi-
experimental design.
Compare outcomes
between two treatments,
tests, or care delivery
models (comparative
effectiveness)
• Does the routine use of pulmonary-artery
catheters improve outcomes for critically ill
patients?(8)
• Do non-physician providers compared to
physicians achieve better or worse mortality
rates for their ICU patients?(124)
High Many therapies in critical care are
confounded by indication - that is, the
choice of treatment depends upon
how sick patients are. Because most
data sources do not collect the
rationale behind medical decision
making, overcoming this bias is
difficult even with detailed data.
Determine the
association between a
risk factor or group of
risk factors and
outcome
• Are septic patients with a trial fibrillation at
greater risk of stroke?(100)
• Can we predict ARDS after trauma?(125)
Moderate Predictive models are usually not
evaluated on variables in model, but
rather on their effectiveness at
determining outcome
Describe epidemiology
of disease, clinical
practice, health service
use, or health care
spending
• What are the longitudinal trends in
hospitalizations for sepsis?(94)
• What proportion of patients who receive CPR in
the ICU are alive at six months?(126)
• To what extent does ICU admission for patients
with DKA vary across hospitals?(99)
Low Descriptive epidemiology questions
rarely require risk adjustment;
comparisons between groups are not
made. Such questions will also
require richer data to approach well.
Evaluate policy or
quality improvement
intervention
• Did participation in a clinical trial of low tidal
volume ventilation in ARDS change clinical
practice?(127)
• Did resident work hour reform impact outcomes
of ICU mortality?(128)
• Did health care reform in Massachusetts result
in changes in ICU utilization rates?(129)
Low Although extensive clinical
information is not often necessary for
such analyses, when present it can
greatly enhance the analysis.
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